Coronavirus disease 2019 (COVID-19) Brazil Task Force: How to navigate troubled waters

• Published in: Infection control and hospital epidemiology Vol. 43; no. 4; pp. 550 - 551
• Main Authors: Carneiro, Marcelo, Hessel Dias, Viviane Maria de Carvalho, Miranda Costa, Magda Machado de, Pinheiro, Débora Otero Britto Passos, Vidal, Cláudia Fernanda de Lacerda, Rodrigues, Olívia Cristina Palmeira da Silva, Corradi, Mirian de Freitas Dal Ben, Santana, Heiko Thereza, Nogueira, Maria Dolores Santos da Purificação, Gonçalves, Mara Rúbia Santos, Padoveze, Maria Clara
• Format: Journal Article
• Language: English
• Published: New York, USA Cambridge University Press 01.04.2022
• Subjects: Advisory Committees; Brazil - epidemiology; Cooperation; Coronaviruses; COVID-19; Disease control; Disease prevention; Disease transmission; Health care; Health services; Hospital costs; Humans; Infections; Letter to the Editor; Pandemics; Professionals; Public health; SARS-CoV-2; Task forces; Brazil
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1017/ice.2021.41

To date, 4 documents have been developed by this task force and have been published by ANVISA: (1) Technical note on the guidelines for health services: prevention and control measures that must be adopted when assisting suspected or confirmed cases of infection by the new coronavirus; (2) technical note on the guidelines for the prevention and control of infections by the new coronavirus in surgical procedures; (3) a review of all the scientific evidence accumulated to date on COVID-19; and (4) guidelines for preventing the transmission of COVID-19 in the health services.6–9 However, we are aware that the problems related to the structure, training, and monitoring in health institutions have been a constant challenge in most hospitals, mainly those with already insufficient structure.10 These challenges include the shortage of PPE in some regions of the country, which has led to a market of low-quality products and increased hospital costs. [...]this initiative has enlarged the channels of dissemination of guidance related to COVID-19 prevention and control, which will contribute to greater adherence. [...]this low-cost initiative may become an example for similar future cooperation related to other challenges of common interest, such as antimicrobial resistance.